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EDITORIAL
The response to loss of function of one kidney: It all depends
upon what is happening next door
The fact that live donors can give away one kidney for
transplantation and rest assured that their remaining kid-
ney will compensate to do the job of two kidneys within a
short period of time [1] is probably the single most impor-
tant reason why the expansion of renal transplantation
has occurred in recent years. But the mystery remains
about what the signals are that the remaining kidney re-
ceives in order to achieve this feat. Certainly, the process
of enlargement, which is largely one of hypertrophy, is
very different from the hyperplastic (proliferative) re-
sponse that occurs in the liver when part of its mass is
deleted [2].
It has always been assumed that loss of function in
some ways triggers a humoral and/or a neurovascular re-
sponse in the surviving kidney when the function of its
partner is lost. In this issue of Kidney International, us-
ing a sophisticated molecular genetic approach, Hauser
et al now show us that loss of function is not quite so
simple [3]. By conducting a genome-wide expression and
transcription factor analysis linked to histomorphome-
try, they have found that loss of function, per se, cannot
be the whole story. For, if uninephrectomy (UN) is per-
formed and compared with unilateral ureteral obstruc-
tion (UUO) in rats, the patterns of gene expression in the
remaining kidney are very different in the two situations.
The first finding of importance is that those transcripts
that are differentially expressed compared with the con-
trol situation (the untouched kidney) are largely sup-
pressed in both UN and UUO and many of these are
genes which encode for growth inhibitors and apopto-
sis. Thus, in both situations there is apparently a release
of “normal” growth repression, which allows the kidney
to grow rather than the commonly assumed growth pro-
moter induction.
The idea that down-regulation of growth repressors
may be a more widespread phenomenon finds support in
a recently published study of cardiac hypertrophy where
the details are more well defined [4]. Factors that induce
hypertrophy of the heart (overexpression of b-adrenergic
receptors or pressure overload) also induce expression of
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the transcriptional corepressor NGFI-A binding protein
1 (NAB1) in the myocardium [5]. NAB1 binds to the early
growth response gene Egr-1 in hearts exposed to adren-
ergic stimulation and that exhibit hypertrophy. Such hy-
pertrophy does not occur in NAB1 transgenic mice which
overexpress the gene product. (This ability of NAB1 to in-
hibit pathological cardiac hypertrophy, interestingly, does
not influence physiologic hypertrophy induced by run-
ning exercise). Thus, pathologic hypertrophic stimuli that
induce Egr-1 also induce repressors of Egr-1, which pre-
sumably limit the hypertrophic response [6].
Extrapolating from this, it would be reasonable to pre-
sume that suppression of NAB1 expression could, per
se, lead to hypertrophy. It would be of interest to know
whether knocking out NAB1 has such an effect in vivo
and whether this would occur in multiple organs. Simi-
larly, now that it is apparent that the renal hypertrophic
response to uninephrectomy includes down-regulation of
repressor genes [3], it would be of great interest to know
whether there is a hierarchy of such factors, and whether
decreased expression of only one or two key molecules
could lead to hypertrophy. This will certainly be an im-
portant direction for future research.
However, as Hauser et al [3] show, this is only part of
the story. Their second finding of importance is that, in
UUO, the remaining kidney activates genes that regu-
late important solute and water transport pathways (e.g.,
aquaporins), whereas in UN, cell cycle regulatory genes
(e.g., cyclins), are activated. All of this occurs with no
noticeable changes in renal histomorphometry. Thus, the
patterns of gene expression are very different in the two
models of loss of unilateral function.
If these findings are applied to human disease in con-
texts other than organ donation, a number of interest-
ing scenarios can be considered. First, by understanding
the unique signals that are received by the kidney when
its partner becomes obstructed, we may be able to get
a handle on how to activate selectively certain transport
functions. Next, if we can understand how it is that cy-
clin genes are activated, we could, at least in theory, have
an approach to augmenting certain renal function by ma-
nipulating the growth response of nephrons in diseased
kidneys. At least one candidate molecule was identified
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in the studies of Hauser et al [3], and that is insulin-like
growth factor 2 binding protein. This was continuously
up-regulated over a period of three days but its pre-
cise role is not clear and why it is selectively affected is
equally obscure. Finally, since several ubiquitin proteases
were suppressed and these proteins play a role in protein
degradation, manipulating these proteins could provide
a new approach to targeted renal growth [7].
The pathways that alter the function of the contralat-
eral kidney in UUO are intriguing. If, in UUO, there are
humoral factors that are either released or metabolized in
a way which is not normal, why do these not affect other
tissues? One answer, based on the study of Hauser et al
[3], could be that they act selectively on those genes that
are relatively (but not completely) unique to the kidney,
namely genes that encode for transport functions. Could
it be that, if carefully looked for, other tissues which ex-
press these genes are also activated in UUO? Or is it that
the remaining kidney is “primed” by a neural or vascular
response that is different from that which occurs in UN
and that makes it “susceptible” to humoral influences?
These questions are amenable to investigation.
It is, of course, as important to understand the patterns
of gene expression (i.e., sets of genes with similar func-
tions), as it is to understand the expression of individual
genes. It is this insight that will open the door to the re-
alization that different pathologic situations may show
patterns of gene activation that lead to different effects
on surviving nephrons in a diseased kidney and/or in the
kidney. The current ability to do genome-wide analyses
[8, 9] in kidney tissue will allow us to gain further insights
along these lines.
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